Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...
Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...
While rare, serious side effects can happen on Ozempic. These include pancreatitis (inflammation of the pancreas), diabetic retinopathy (diabetes-related vision changes), hypoglycemia, serious ...
People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.
The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Citizens Medical Center Cardiologist Dr. Kurtis Kreuger won’t sugar coat it. Because of its direct correlation to heart ...
4d
Irish Examiner on MSNOn the rebound: What are the long-term risks of Ozempic?Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...
Specialists say that overweight people who have cancer or need a transplant are using weight loss medication before the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results